These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36365078)

  • 1. Optimization of In Vivo Electroporation Conditions and Delivery of DNA Vaccine Encoding SARS-CoV-2 RBD Using the Determined Protocol.
    Kisakov DN; Kisakova LA; Borgoyakova MB; Starostina EV; Taranov OS; Ivleva EK; Pyankov OV; Zaykovskaya AV; Shcherbakov DN; Rudometov AP; Rudometova NB; Volkova NV; Gureev VN; Ilyichev AA; Karpenko LI
    Pharmaceutics; 2022 Oct; 14(11):. PubMed ID: 36365078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization of electroporation-enhanced intradermal delivery of DNA vaccine using a minimally invasive surface device.
    Lin F; Shen X; Kichaev G; Mendoza JM; Yang M; Armendi P; Yan J; Kobinger GP; Bello A; Khan AS; Broderick KE; Sardesai NY
    Hum Gene Ther Methods; 2012 Jun; 23(3):157-68. PubMed ID: 22794496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel prototype device for electroporation-enhanced DNA vaccine delivery simultaneously to both skin and muscle.
    Lin F; Shen X; McCoy JR; Mendoza JM; Yan J; Kemmerrer SV; Khan AS; Weiner DB; Broderick KE; Sardesai NY
    Vaccine; 2011 Sep; 29(39):6771-80. PubMed ID: 21199706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electroporation mediated DNA vaccination directly to a mucosal surface results in improved immune responses.
    Kichaev G; Mendoza JM; Amante D; Smith TR; McCoy JR; Sardesai NY; Broderick KE
    Hum Vaccin Immunother; 2013 Oct; 9(10):2041-8. PubMed ID: 23954979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integration of needle-free jet injection with advanced electroporation delivery enhances the magnitude, kinetics, and persistence of engineered DNA vaccine induced immune responses.
    Jiang J; Ramos SJ; Bangalore P; Fisher P; Germar K; Lee BK; Williamson D; Kemme A; Schade E; McCoy J; Muthumani K; Weiner DB; Humeau LM; Broderick KE
    Vaccine; 2019 Jun; 37(29):3832-3839. PubMed ID: 31174938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-Assembled Particles Combining SARS-CoV-2 RBD Protein and RBD DNA Vaccine Induce Synergistic Enhancement of the Humoral Response in Mice.
    Borgoyakova MB; Karpenko LI; Rudometov AP; Volosnikova EA; Merkuleva IA; Starostina EV; Zadorozhny AM; Isaeva AA; Nesmeyanova VS; Shanshin DV; Baranov KO; Volkova NV; Zaitsev BN; Orlova LA; Zaykovskaya AV; Pyankov OV; Danilenko ED; Bazhan SI; Shcherbakov DN; Taranin AV; Ilyichev AA
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel DNA Vaccine Against SARS-CoV-2 Encoding a Chimeric Protein of Its Receptor-Binding Domain (RBD) Fused to the Amino-Terminal Region of Hepatitis B Virus preS1 With a W4P Mutation.
    Jeong H; Choi YM; Seo H; Kim BJ
    Front Immunol; 2021; 12():637654. PubMed ID: 33732258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and immunogenicity of a live-attenuated influenza virus vector-based intranasal SARS-CoV-2 vaccine in adults: randomised, double-blind, placebo-controlled, phase 1 and 2 trials.
    Zhu F; Zhuang C; Chu K; Zhang L; Zhao H; Huang S; Su Y; Lin H; Yang C; Jiang H; Zang X; Liu D; Pan H; Hu Y; Liu X; Chen Q; Song Q; Quan J; Huang Z; Zhong G; Chen J; Han J; Sun H; Cui L; Li J; Chen Y; Zhang T; Ye X; Li C; Wu T; Zhang J; Xia NS
    Lancet Respir Med; 2022 Aug; 10(8):749-760. PubMed ID: 35644168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo electroporation of minicircle DNA as a novel method of vaccine delivery to enhance HIV-1-specific immune responses.
    Wang Q; Jiang W; Chen Y; Liu P; Sheng C; Chen S; Zhang H; Pan C; Gao S; Huang W
    J Virol; 2014 Feb; 88(4):1924-34. PubMed ID: 24284319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electroporation of a nanoparticle-associated DNA vaccine induces higher inflammation and immunity compared to its delivery with microneedle patches in pigs.
    Bernelin-Cottet C; Urien C; McCaffrey J; Collins D; Donadei A; McDaid D; Jakob V; Barnier-Quer C; Collin N; Bouguyon E; Bordet E; Barc C; Boulesteix O; Leplat JJ; Blanc F; Contreras V; Bertho N; Moore AC; Schwartz-Cornil I
    J Control Release; 2019 Aug; 308():14-28. PubMed ID: 31265882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An ultra-low-cost electroporator with microneedle electrodes (ePatch) for SARS-CoV-2 vaccination.
    Xia D; Jin R; Byagathvalli G; Yu H; Ye L; Lu CY; Bhamla MS; Yang C; Prausnitz MR
    Proc Natl Acad Sci U S A; 2021 Nov; 118(45):. PubMed ID: 34670842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Markedly enhanced immunogenicity of a Pfs25 DNA-based malaria transmission-blocking vaccine by in vivo electroporation.
    LeBlanc R; Vasquez Y; Hannaman D; Kumar N
    Vaccine; 2008 Jan; 26(2):185-92. PubMed ID: 18054817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Humoral and Cellular Immune Responses to Vector, Mix-and-Match, or mRNA Vaccines against SARS-CoV-2 and the Relationship between the Two Immune Responses.
    Nam M; Yun SG; Kim SW; Kim CG; Cha JH; Lee C; Kang S; Park SG; Kim SB; Lee KB; Chung YS; Nam MH; Lee CK; Cho Y
    Microbiol Spectr; 2022 Aug; 10(4):e0249521. PubMed ID: 35946811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine in Chinese adults: a randomised, double-blind, placebo-controlled, phase 1 trial.
    Chen GL; Li XF; Dai XH; Li N; Cheng ML; Huang Z; Shen J; Ge YH; Shen ZW; Deng YQ; Yang SY; Zhao H; Zhang NN; Zhang YF; Wei L; Wu KQ; Zhu MF; Peng CG; Jiang Q; Cao SC; Li YH; Zhao DH; Wu XH; Ni L; Shen HH; Dong C; Ying B; Sheng GP; Qin CF; Gao HN; Li LJ
    Lancet Microbe; 2022 Mar; 3(3):e193-e202. PubMed ID: 35098177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant
    Kim BJ; Jeong H; Seo H; Lee MH; Shin HM; Kim BJ
    Front Immunol; 2021; 12():712274. PubMed ID: 34512635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mosaic-type trimeric RBD-based COVID-19 vaccine candidate induces potent neutralization against Omicron and other SARS-CoV-2 variants.
    Zhang J; Han ZB; Liang Y; Zhang XF; Jin YQ; Du LF; Shao S; Wang H; Hou JW; Xu K; Lei W; Lei ZH; Liu ZM; Zhang J; Hou YN; Liu N; Shen FJ; Wu JJ; Zheng X; Li XY; Li X; Huang WJ; Wu GZ; Su JG; Li QM
    Elife; 2022 Aug; 11():. PubMed ID: 36004719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models.
    Conforti A; Marra E; Palombo F; Roscilli G; Ravà M; Fumagalli V; Muzi A; Maffei M; Luberto L; Lione L; Salvatori E; Compagnone M; Pinto E; Pavoni E; Bucci F; Vitagliano G; Stoppoloni D; Pacello ML; Cappelletti M; Ferrara FF; D'Acunto E; Chiarini V; Arriga R; Nyska A; Di Lucia P; Marotta D; Bono E; Giustini L; Sala E; Perucchini C; Paterson J; Ryan KA; Challis AR; Matusali G; Colavita F; Caselli G; Criscuolo E; Clementi N; Mancini N; Groß R; Seidel A; Wettstein L; Münch J; Donnici L; Conti M; De Francesco R; Kuka M; Ciliberto G; Castilletti C; Capobianchi MR; Ippolito G; Guidotti LG; Rovati L; Iannacone M; Aurisicchio L
    Mol Ther; 2022 Jan; 30(1):311-326. PubMed ID: 34547465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influenza A vaccines using linear expression cassettes delivered via electroporation afford full protection against challenge in a mouse model.
    Shen X; Söderholm J; Lin F; Kobinger G; Bello A; Gregg DA; Broderick KE; Sardesai NY
    Vaccine; 2012 Nov; 30(48):6946-54. PubMed ID: 22406460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of humoral immunity of hepatitis D virus DNA vaccine generated in mice by using different dosage, gene gun immunization, and in vivo electroporation.
    Shiau YT; Huang YH; Wu JC; Tao MH; Syu W; Chang FY; Lee SD
    J Chin Med Assoc; 2006 Jan; 69(1):7-13. PubMed ID: 16447920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicity and Local Tolerance of COVID-
    Ramot Y; Caselli G; Aurisicchio L; Andreini I; Marra E; Luberto L; Stoppoloni D; Pacello ML; Monetini L; Nyska A
    Toxicol Pathol; 2021 Oct; 49(7):1255-1268. PubMed ID: 34493107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.